Cargando…

Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes

BACKGROUND: The 2019 guidelines for cardiovascular risk stratification by the European Society of Cardiology and European Association for the Study of Diabetes (ESC-EASD) suggested screening for silent coronary disease in very high risk patients with severe target organ damage (TOD) (i.e. peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valensi, Paul, Berkane, Narimane, Pinto, Sara, Sellier, Nicolas, Soussan, Michael, Nguyen, Minh Tuan, Cosson, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930289/ https://www.ncbi.nlm.nih.gov/pubmed/36793073 http://dx.doi.org/10.1186/s12933-023-01760-4

Ejemplares similares

Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study
por: Cosson, Emmanuel, et al.
Publicado: (2021)

Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
por: Valensi, Paul, et al.
Publicado: (2016)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study
por: Cosson, Emmanuel, et al.
Publicado: (2021)

Cardiovascular Risk Prediction Is Improved by Adding Asymptomatic Coronary Status to Routine Risk Assessment in Type 2 Diabetic Patients
por: Cosson, Emmanuel, et al.
Publicado: (2011)

Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients
por: Nguyen, Minh Tuan, et al.
Publicado: (2014)

ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging
por: Saraste, Antti, et al.
Publicado: (2020)

COVID-19 pandemic: Can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy?
por: Nachtergaele, Charlotte, et al.
Publicado: (2021)

The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
por: Schnell, Oliver, et al.
Publicado: (2009)

Highlights vom EASD 2022
por: Stiefelhagen, Peter
Publicado: (2022)

Impact of experiencing multiple vulnerabilities on fetal growth and complications in women with hyperglycemia in pregnancy
por: Bihan, Helene, et al.
Publicado: (2023)

Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients
por: Pham, Isabelle, et al.
Publicado: (2015)

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC()
por: Bloomgarden, Zachary, et al.
Publicado: (2020)

Abbreviated lipid guidelines for clinical practice: Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021
por: Maher, Vincent, et al.
Publicado: (2023)

Limiting the Use of Oral Glucose Tolerance Tests to Screen for Hyperglycemia in Pregnancy during Pandemics
por: Nachtergaele, Charlotte, et al.
Publicado: (2021)

The changing landscape of scientific communication at EASD
por: Mathieu, Chantal, et al.
Publicado: (2022)

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Publicado: (2016)

Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2016)

Abstracts of 52nd EASD Annual Meeting
Publicado: (2016)

Abstracts of the 49th Annual Meeting of the EASD
Publicado: (2013)

Prognosis Associated with Sub-Types of Hyperglycaemia in Pregnancy
por: Cosson, Emmanuel, et al.
Publicado: (2021)

Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2018)

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2019)

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Glycation Gap Is Associated With Macroproteinuria but Not With Other Complications in Patients With Type 2 Diabetes
por: Cosson, Emmanuel, et al.
Publicado: (2013)

Diagnostic and Prognostic Performances Over 9 Years of a Selective Screening Strategy for Gestational Diabetes Mellitus in a Cohort of 18,775 Subjects
por: Cosson, Emmanuel, et al.
Publicado: (2013)

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
por: Prausmüller, Suriya, et al.
Publicado: (2021)

The impact and challenges of implementing CTCA according to the 2019 ESC guidelines on chronic coronary syndromes: a survey and projection of CTCA services in the Netherlands
por: van den Boogert, T. P. W., et al.
Publicado: (2021)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

Association Between Adherence To The French Dietary Guidelines And Lower Resting Heart Rate, Longer Diastole Duration, And Lower Myocardial Oxygen Consumption. The NUTRIVASC Study
por: Fysekidis, Marinos, et al.
Publicado: (2019)

57 (th) EASD Annual Meeting of the European Association for the Study of Diabetes
Publicado: (2021)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021)

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease()
por: Dykun, Iryna, et al.
Publicado: (2018)

Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia Guidelines
por: Haegele, Matthias, et al.
Publicado: (2022)

Rtt107/Esc4 binds silent chromatin and DNA repair proteins using different BRCT motifs
por: Zappulla, David C, et al.
Publicado: (2006)

Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
por: Floyd, Christopher N
Publicado: (2020)

Implications of Alterations in Pre-test Probability in the 2019 Update of ESC Guidelines for Chronic Coronary Syndromes on Diagnostic Accuracy of Pharmacological Stress-Echocardiography: A Retrospective Cohort Study
por: Dykun, Iryna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_266rqtgn0sagekmuob7hmtgl56